Andrea D. Gelzer, MD

Articles by Andrea D. Gelzer, MD

Collaborative DTM Reduces Hospitalization and Healthcare Costs in Patients With Diabetes Treated With Polypharmacy

ByLauren Brophy, PharmD, FAHM,Amanda Williams, PharmD,Eric J. Berman, DO, MS,David Keleti, PhD,Karen E. Michael, RN, MSN, MBA,Margaret Shepherd, RPh, FAHM,Scott A. Fox, MS, MEd,Christine Jacobs, MA,Susan Tan-Torres, MD, MPH,Andrea D. Gelzer, MD,Mesfin Tegenu, MS, RPh

March 14th 2014

Drug therapy management implementation in 2 health plans resulted in significant cost savings and modest to significant reductions in emergency department visits and inpatient admissions among patients with diabetes.

Latest Updated Articles

Collaborative DTM Reduces Hospitalization and Healthcare Costs in Patients With Diabetes Treated With Polypharmacy
Published: March 14th 2014 | Updated:

Andrea D. Gelzer, MD

Articles by Andrea D. Gelzer, MD

Collaborative DTM Reduces Hospitalization and Healthcare Costs in Patients With Diabetes Treated With Polypharmacy

Latest Updated Articles

Trending on AJMC

IEHP CEO Weighs in: Who Pays the Price When Millions Lose Medicaid Coverage?

FDA Approves Belantamab Mafodotin Combo for Relapsed or Refractory Multiple Myeloma

FDA Approves Elinzanetant, a Hormone-Free Option for Hot Flashes in Menopause

Eliminating Cost Sharing Boosted Follow-Up Colonoscopy Rates

Revumenib Granted FDA Approval for R/R NPM1-Mutated AML